Adult Immunization Updates

Critical delay hits adult COVID data: A CDC study on how vaccines reduced ER visits and hospitalizations in healthy adults during 2025...

• Expanded eligibility: New charter adds expertise in vaccine injury recovery, potentially allowing prior critics back on panel.
• Court trigger:...

NIAC guidelines now allow twice-yearly COVID-19 vaccines for adults aged 18+ and 80+ in the GP seasonal campaign. Key for planning personal boosters this season.

• 32 measles cases across Washington counties, amid 1,671 US cases in 33 states incl. WA, ID, OR
• Risks: 50% hospitalization in kids under 5, immune...

Court Blocks on Vaccine Policy Changes

• 🔥 Judge Halts RFK Jr. Overhaul: A federal judge in Massachusetts blocked Robert F. Kennedy Jr.'s...

Federal judge in Massachusetts blocks Health Secretary Robert F. Kennedy Jr.'s overhaul of the childhood vaccine schedule – a major check on HHS policy shifts that supports stability in vaccine recommendations for family health.

• Universal flu vaccine aims at hemagglutinin stalk for lasting protection, ditching yearly reformulations and variable efficacy.
• TB vaccine...

Tailor vaccines to your risks: Shared clinical decision-making means providers and patients discuss benefits vs. individual needs—standard for adult...

Worrying trend for adult COVID boosters under new leadership:

• ACIP overhaul: RFK Jr. replaced members; new charter allows skeptics, emphasizes...

Key AIM updates on 2026 legislative action:

• 12 sessions ended, 9 more wrapping up this month
• Tracking 417 bills introduced/advanced since Aug 1...

Critical evidence on adult COVID vaccine effectiveness is stalled:

• Vaccinated healthy adults saw 50% fewer emergency/urgent care visits and 55%...

Maine's aging population (23.5% 65+ in 2025) demands focus on adult vaccines like flu, COVID-19, RSV, shingles.

• Federal politics removed COVID...

Lyme Vaccine Progress

• 🔥 Pfizer/Valneva Phase 3 Results: Pfizer and Valneva announced positive results from their phase 3 trial of a Lyme...

• Key evidence: COVID-19 vaccines cut emergency visits and hospitalizations by half for healthy adults last winter – vital for personal health...

Promising but cautious outlook for Lyme vaccine approval amid rising U.S. cases (~476K/year):

• Phase 3 efficacy: 73-75% effective; data submitted to...

Key insights from NEJM letter on DANFLU-2 trial for older adults:

• 61.5% got flu and COVID vaccines same day, matching current practice.
  -...

RSV Vaccine Effectiveness in Adults

• 🔥 Waning Protection in Nursing Homes: Study of 15,078 nursing home residents showed Abrysvo vaccine...

New PHAC data via CAEFISS (2020-2026) reveals 314 reported deaths post-COVID vaccination, mostly within 2 days from cardiac events, strokes, seizures,...

• IDF supports broad RSV vaccination for immunocompromised adults, following AAFP guidelines.
• Abrysvo shows steady protection (77%) for nursing home...

Legal hurdle: Judge ruled RFK Jr.'s ACIP replacements—mostly vaccine skeptics—'distinctly unqualified,' halting their decisions after he removed all...